Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
24.81
-2.18 (-8.06%)
At close: Aug 27, 2025, 4:00 PM
25.10
+0.30 (1.19%)
Pre-market: Aug 28, 2025, 5:13 AM EDT

Summit Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
18,42613,1601,829897263387
Upgrade
Market Cap Growth
188.63%619.43%103.94%241.23%-32.01%-28.06%
Upgrade
Enterprise Value
18,13412,7051,737779184366
Upgrade
Last Close Price
24.8017.842.614.252.694.70
Upgrade
PS Ratio
---1272.24145.30449.56
Upgrade
PB Ratio
71.0233.8523.547.083.164.87
Upgrade
P/TBV Ratio
71.5934.0224.137.183.715.87
Upgrade
EV/Sales Ratio
---1105.42101.96425.47
Upgrade
Debt / Equity Ratio
0.020.021.374.100.030.01
Upgrade
Asset Turnover
---0.000.020.01
Upgrade
Quick Ratio
4.949.909.179.153.473.85
Upgrade
Current Ratio
5.1310.159.3016.933.804.41
Upgrade
Return on Equity (ROE)
-328.30%-94.89%-601.85%-75.05%-108.89%-66.57%
Upgrade
Return on Assets (ROA)
-142.53%-41.30%-12.79%-10.23%-49.91%-32.91%
Upgrade
Return on Capital (ROIC)
-166.87%-45.49%-13.38%-10.87%-64.91%-40.97%
Upgrade
Earnings Yield
-4.05%-1.68%-33.62%-8.78%-33.71%-13.63%
Upgrade
FCF Yield
-1.13%-1.08%-4.20%-4.71%-27.73%-12.55%
Upgrade
Buyback Yield / Dilution
-4.79%-15.96%-220.50%-109.60%-32.67%-111.78%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q